Native HMGB1 protein inhibits repair of cisplatin-damaged nucleosomes in vitro

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 7, 2009, Pages 1556-1562

  Ugrinova, Iva ^a   Zlateva, Stanislava ^a   Pashev, Iliya G ^a   Pasheva, Evdokia A ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Bulgaria)

Author keywords

Acetylation; Cisplatin damaged nucleosomes; DNA repair; HMGB1 protein; Nucleosome reconstitution

Indexed keywords

CISPLATIN; DNA; HIGH MOBILITY GROUP B1 PROTEIN; PROTEIN KINASE C;

ACETYLATION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ENZYME RECONSTITUTION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEOSOME; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT;

ACETYLATION; ANIMALS; CELL-FREE SYSTEM; CISPLATIN; DNA DAMAGE; DNA REPAIR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HMGB1 PROTEIN; MUTANT PROTEINS; NUCLEOSOMES; PHOSPHORYLATION; PROTEIN KINASE C; RATS; RECOMBINANT PROTEINS; TRYPSIN;

EID: 63049132136     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.01.010     Document Type: Article

References (40)

1. An W., van Holde K., and Zlatanova J. The non-histone chromatin protein HMG1 protects linker DNA on the side opposite to that protected by the linker histones. J Biol Chem 273 (1998) 26289-26291
2. Ausio J., Dong F., and van Holde K. Use of selectively trypsinized nucleosome core particles to analyze the role of the histone tails in the stabilization of the nucleosomes. J Mol Biol 206 (1989) 451-463
3. Bellon S.F., Coleman J.H., and Lippard S.J. DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum(II). Biochemistry 30 (1991) 8026-8035
4. Biade S., Sobol R.W., Wilson S.H., and Matsumoto Y. Impairment of proliferating cell nuclear antigen-dependent apurinic/apyrimidinic site repair on linear DNA. J Biol Chem 273 (1998) 898-902
5. Bonaldi T., Längst G., Strohner R., Becker P.B., and Bianchi M.E. The DNA chaperone HMGB1 facilitates ACF/CHRAC-dependent nucleosome sliding. EMBO J 21 (2002) 6865-6873
6. Brown S.J., Kellet P.J., and Lippard S.J. Ixr1, a yeast protein that binds to platinated DNA confers sensitivity to cisplatin. Science 261 (1993) 603-605
7. Chu G. Cellular responses to cisplatin, The role of DNA binding proteins and DNA repair. J Biol Chem 269 (1994) 787-790
8. Eastman A. Re-evaluation of interactions of cis-dichloro-(ethylendiamnine)platinum(II) with DNA. Biochemistry 25 (1986) 3912-3915
9. Fachtinger-Schepman A.M.J., van der Veer J.L., den Hartog J.H.J., Lohman P.H.M., and Reedijk J. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry 24 (1985) 707-713
10. Haves H., and Scovell W.M. Cis-diamminedichloroplatinum(II) modified chromatin and nucleosomal core particle. Biochim Biophys Acta 1089 (1991) 377-385
11. He Q., Liang C.H., and Lippard S.J. Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin. Proc Natl Acad Sci USA 97 (2000) 5768-5772
12. Huang J.-C., Zamble D.B., Reardon J.T., Lippard S.J., and Sancar A. HMG domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by humane excision nuclease. Proc Natl Acad Sci USA 91 (1994) 10394-10398
13. Hughes E.N., Engelsberg B.N., and Billings P.C. Purification of nuclear proteins that bind to cisplatin-damaged DNA: identity with high mobility group proteins 1 and 2. J Biol Chem 267 (1992) 13520-13527
14. Jamielson E.R., and Lippard S.J. Structure, recognition, and processing of cisplatin-DNA adducts. Chem Rev 99 (1999) 2467-2498
15. Li L., Liu X., Glassmann A.B., Keating M.J., Stros M., Plunkett W., et al. Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro. Cancer Res 57 (1997) 1487-1494
16. Lichota J., and Grasser K.D. Interaction of maize chromatin-associated HMG proteins with mononuclesomes: role of core and linker histones. Biol Chem 384 (2003) 1019-1027
17. Lippard S.J., and Hoeschele J.D. Binding of cis-and trans dichlorodiammineplatinum(II) to the nucleosome core. Proc Natl Acad Sci USA 76 (1979) 6091-6095
18. Lowary P.T., and Widom J. New DNA sequence rules for high affinity binding to histone octamer and sequence-directed nucleosome positioning. J Mol Biol 276 (1998) 19-42
19. Millard J.T., and Wilkes E.E. cis- and trans-Diamminedichlorplatinum(II) interstrand cross-linking of a defined sequence nucleosomal core particle. Biochemistry 39 (2000) 16046-16055
20. Mitkova E., Ugrinova I., Pashev I.G., and Pasheva E.A. The inhibitory effect of HMGB1 protein on the repair of cisplatin-damaged DNA is accomplished through the acidic domain. Biochemistry 44 (2005) 5893-5898
21. Mutskov V., Gerber D., Angelov D., Ausio J., Workman J., and Dimitrov S. Persistent interactions of core histone tails with nucleosomal DNA following acetylation and transcription factor binding. Mol Cell Biol 18 (1998) 6293-6304
22. Nagatani G., Nomoto M., Takano H., Ise T., Kato K., Imamura T., et al. Transcriptional activation of the human HMG1 gene in cisplatin-resistant human cancer cells. Cancer Res 61 (2001) 1592-1597
23. Nightingel U., Dimitrov S., Reeves R., and Wolffe A. Evidence for a shared structural role for HMG1 and linker histones B4 and H1 in organizing chromatin. EMBO J 15 (1996) 548-561
24. Peterson C.L., and Cote J. Cellular machineries for chromosomal DNA repair. Genes Dev 18 (2004) 602-616
25. Pil P.M., and Lippard S.J. Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin. Science 236 (1992) 234-237
26. Reeves R., and Adair J.E. Role of high mobility group (HMG) chromatin proteins in DNA repair. DNA Rep 4 (2005) 926-938
27. Satoh M.S., and Lindahl J. Role of poly(ADP-ribose) formation in DNA repair. Nature 356 (1992) 356-358
28. Schroter H., and Bode J. The binding site for large and small high-mobility-group (HMG) proteins studies on HMG-nucleosome interactions in vitro. Eur J Biochem 127 (1982) 429-436
29. Simon R.H., and Felsenfeld G. A new procedure for purifying histone pairs H2A+H2B and H3+H4 from chromatin using hydroxylapatite. Nucleic Acids Res 6 (1979) 689-696
30. Smerdon M.J., and Conconi A. Modulation of DNA damage and DNA repair in Chromatin. Progr Nucl Acid Res Mol Biol 62 (1999) 227-255
31. Stros M., Stokrova J., and Thomas J.O. DNA looping by the HMG-box domains of HMG1 and modulation of DNA binding by the acidic C-terminal domain. Nucleic Acids Res 22 (1994) 1044-1051
32. Tanaka M., Lai L.S., and Herr W. Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of a snRNA and mRNA promoter. Cell 68 (1992) 755-767
33. Topalova D., Ugrinova I., Pashev I.G., and Pasheva E.A. HMGB1 protein inhibits DNA replication in vitro: a role of the acetylation and the acidic tail. Int J Biochem Cell Biol 40 (2008) 1536-1542
34. Ueda T., Chou H., Kawase T., Shirakawa H., and Yoshida M. Acidic C-tail of HMGB1 is required for its target binding to nucleosome linker DNA and transcription stimulation. Biochemistry 43 (2004) 9901-9908
35. Ugrinova I., Pasheva E.A., Armengaud J., and Pashev I.G. In vivo acetylation of HMG1 protein enhances its binding affinity to distorted DNA structures. Biochemistry 40 (2001) 14655-14660
36. Wang D., Hara R., Singh G., Sancar A., and Lippard S.J. Nucleotide excision repair from site-specifically platinum-modified nucleosomes. Biochemistry 42 (2003) 6747-6753
37. Widlak P., Pietrowska M., and Lanuszewska J. The role of chromatin proteins in DNA damage recognition and repair. Histochem Cell Biol 125 (2006) 119-126
38. Zamble D.B., and Lippard S.J. Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem Sci 20 (1995) 435-439
39. Zamble D.B., Mu D., Reardon J.T., Sancar A., and Lippard S.J. Repair of cisplatin-DNA adducts by the mammalian excision nuclease. Biochemistry 35 (1996) 10004-10013
40. Zlatanova J., Yaneva J., and Leuba S.H. Proteins that specifically recognize cisplatin-damaged DNA: a clue to anticancer activity of cisplatin. FASEB J 12 (1998) 791-799